J9247 — Injection, melphalan flufenamide, 1mg
J9247 is a HCPCS Level II code for injection, melphalan flufenamide, 1mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on March 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J9247 on March 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9247
- Long descriptor
- Injection, melphalan flufenamide, 1mg
- Short descriptor
- Inj, melphalan flufenami 1mg
- Added
- October 1, 2021
- Terminated
- March 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9247
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9247 is not quite right, the correct code is very often within a few positions of it.
- J9226Histrelin implant (supprelin la), 50 mg
- J9227Injection, isatuximab-irfc, 10 mg
- J9228Injection, ipilimumab, 1 mg
- J9229Injection, inotuzumab ozogamicin, 0.1 mg
- J9230Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
- J9232Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg
- J9245Injection, melphalan hydrochloride, not otherwise specified, 50 mg
- J9246Injection, melphalan (evomela), 1 mg
- J9248Injection, melphalan (hepzato), 1 mg
- J9249Injection, melphalan (apotex), 1 mg
- J9250Methotrexate sodium, 5 mgterminated
- J9255Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
- J9256Injection, nipocalimab-aahu, 3 mg
- J9258Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mgterminated
- J9259Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mgterminated
- J9260Injection, methotrexate sodium, 50 mg
Questions about J9247
What is HCPCS code J9247?
J9247 is a HCPCS Level II code for injection, melphalan flufenamide, 1mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9247?
The CMS HCPCS file marks J9247 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J9247 still valid?
No. J9247 was terminated on March 31, 2025 and should not be used on new claims.